| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC3447 |
| Trial ID | NCT05868083 |
| Disease | Glioblastoma Multiforme |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SNC-109 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma |
| Year | 2023 |
| Country | China |
| Company sponsor | Shanghai Simnova Biotechnology Co., Ltd. |
| Other ID(s) | SNC-109-101 |
| Cohort 1 | |||||||||
|
|||||||||